马里兰州与药厂 Indivior 达成350万美元和解:逾150万美元赔付加200万美元治疗药物

马里兰州总检察长 Anthony G. Brown 11月16日宣布,该州已与制药企业 Indivior 达成最终和解。Indivior 生产治疗阿片类药物使用障碍的产品。按和解,马里兰州及其地方将获得逾150万美元的阿片类药物治理资金,另获得价值200万美元的阿片类药物使用障碍治疗药物;现金与药物都将由该州及地方用于增加治疗资源、继续应对阿片类药物流行。马里兰州与 Indivior 的同意判决已在 Frederick 县巡回法院登记。
Brown 说,制药企业必须为不负责任地营销其产品承担责任,这份协议限制了 Indivior 的推广活动,并为受阿片类药物流行重创的马里兰社区送去数百万美元的治疗资源。
Indivior 生产、营销并销售经批准用于治疗阿片类药物使用障碍的丁丙诺啡产品。这类药物在适当的医疗照护与支持下可以成为治疗工具。但马里兰州在11月6日提起的诉状中指控,Indivior 不当营销其产品,且未监测可疑订单。
为解决诉状中的指控,除付款与药物外,和解还对 Indivior 施加了一系列禁令性条款,其中包括限制其产品的部分推广活动、要求任何推广必须真实且不得助长误用,并禁止把销售人员的薪酬或纪律处分与阿片类药物使用障碍产品的销量挂钩。
(来源:马里兰州总检察长办公室)
Maryland Reaches $3.5 Million Settlement With Drug Maker Indivior Over Opioid Treatment Products
BALTIMORE — Maryland Attorney General Anthony G. Brown announced on Nov. 16 that the state has finalized a settlement with drug manufacturer Indivior, which makes products to treat opioid use disorder. Maryland and its subdivisions will receive over $1.5 million in opioid abatement funds, and the settlement also provides Maryland with an additional $2 million in treatment medication for opioid use disorder. Both the cash settlement and the medication will be used by Maryland and its subdivisions to provide additional treatment resources and continue fighting the opioid epidemic. Maryland's consent judgment with Indivior has been entered in the Circuit Court for Frederick County.
"Drug manufacturers must be held accountable for irresponsibly marketing their products," Brown said. "Our agreement sets limits on Indivior's promotions and delivers millions of dollars in treatment to Maryland communities ravaged by the opioid epidemic."
Indivior has manufactured, marketed and sold buprenorphine products approved for the treatment of opioid use disorder. The state alleged in its complaint, filed on Nov. 6, 2026, that Indivior improperly marketed its products and failed to monitor suspicious orders.
To resolve the allegations, in addition to the payment, the settlement imposes injunctive terms on Indivior. Among other requirements, the terms limit some promotional activities for its products, require that any promotion be truthful and not promote misuse, and bar Indivior from tying sales staff pay or discipline to the volume of its opioid use disorder products.
(Source: Maryland Attorney General's Office)
来源:马里兰州总检察长办公室
发布:GSM·美国(发布链接)
图片来源:图:马里兰州议会大厦,位于 Annapolis。CC BY 2.0,经 Wikimedia Commons。 / Photo: The Maryland State House in Annapolis. CC BY 2.0, via Wikimedia Commons.
GSM Global · 本篇英文版 English edition of this story

